Novaferon, a novel recombinant protein produced by DNA-shuffling of IFN-α, shows antitumor effect in vitro and in vivo

来自 EBSCO

阅读量:

120

作者:

M LiC RaoD PeiL WangY LiK GaoM WangJ Wang

展开

摘要:

Objective A recombinant antitumor/antiviral protein (Novaferon, Nova) is a new type of interferon, which is produced by artificial design technology combining DNA-shuffling and High Throughput Screening (HTS). Methods The in vitro biological activities, such as anti-tumor activity and antiviral activity of Nova and recombinant human interferon alpha-2b (rhIFN-??2b) was performed; in vivo anti-tumor activity in nude mice was also tested. Flow cytometry, histo-pathological analysis including HE staining and immunohistochemistry, and surface plasmon resonance assay were performed to investigate the underlying mechanisms analysis. Results Nova exhibited stronger anti-cancer effects compared to rhIFN-??2b in vitro and in vivo. The antitumor mechanisms of Nova may be related to S phase arrest, pro-apoptosis, and inhibition of tumor angiogenesis. Moreover, Nova exhibited a higher binding affinity for IFN receptor 2 (IFNR2) than rhIFN-??2b, which is one of the possible reasons accounting for its stronger actions against tumor cells compared with rhIFN-??2b. Conclusion Nova has strong antitumor activity and could be a potentially effective therapeutic drug for cancer.

展开

DOI:

10.1186/1475-2867-14-8

被引量:

5

年份:

2014

通过文献互助平台发起求助,成功后即可免费获取论文全文。

相似文献

参考文献

引证文献

来源期刊

引用走势

2015
被引量:2

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

引用